Allurion ALUR Plunges 13.8% as Q3 Earnings Concerns Mount Over Deteriorating Revenue Outlook

Generated by AI AgentBefore the BellReviewed byAInvest News Editorial Team
Wednesday, Nov 12, 2025 5:05 am ET1min read
Aime RobotAime Summary

-

(ALUR) plunged 13.8% pre-market as Q3 earnings fears intensified amid sharply deteriorating revenue forecasts.

- 2025 revenue estimates fell to $13.7M (from $28.97M), while 2026 projections dropped further to $13.1M, signaling structural challenges.

- Q2 2025 revenue miss by 43% and mixed analyst opinions highlight growing skepticism despite some optimistic price targets.

- GF Value's $0 valuation vs. brokers' $5.83 target underscores stark divergence between market pessimism and analyst optimism.

On November 12, 2025,

Technologies Inc. (NYSE: ALUR) plummeted 13.7931% in pre-market trading, signaling heightened investor concern ahead of its Q3 earnings report. The sharp decline follows a broader trend of deteriorating revenue estimates and mixed analyst expectations for the year.

Recent data reveals a significant drop in full-year 2025 revenue forecasts, which have fallen from $28.97 million to $13.70 million over 90 days, while 2026 projections have dropped further to $13.10 million. Earnings estimates, though improved for 2025 (from -$32.54 to -$5.04 per share), remain sharply negative and show a worsening trajectory for 2026 (from -$2.96 to -$6.59 per share). This divergence between revenue and earnings suggests structural challenges, particularly as the company’s Q3 2025 earnings are expected to report a loss of $3.77 per share on $2.13 million in revenue.

Historical performance adds to the unease. In Q2 2025, Allurion missed revenue expectations by 43% despite outperforming on earnings. The market reacted with a 1.55% decline post-announcement, indicating skepticism toward improved results. Analysts remain split: while three firms average a $5.83 price target (235% upside from current levels), GuruFocus’ GF Value estimate of $0 implies a total collapse in valuation. The “Outperform” rating from brokers contrasts with the stock’s 88.61% drop over the past 52 weeks, highlighting a disconnect between analyst optimism and recent performance.

Comments



Add a public comment...
No comments

No comments yet